Supraglottis squamous cell carcinoma
disease diseaseOn this page
Also known as epidermoid carcinoma of supraglottisepidermoid carcinoma of the supraglottissquamous cell carcinoma of supraglottissquamous cell carcinoma of the supraglottissupraglottic epidermoid carcinomasupraglottic part of larynx squamous cell carcinomasupraglottic squamous cell carcinomasupraglottis epidermoid carcinoma
Summary
Supraglottis squamous cell carcinoma (MONDO:0004293) is a cancer and 4 clinical trials. A subtype of carcinoma of supraglottis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
- Clinical trials: 4
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | supraglottis squamous cell carcinoma |
| Mondo ID | MONDO:0004293 |
| DOID | DOID:7587 |
| NCIT | C4945 |
| UMLS | C0749163 |
| MedGen | 152890 |
| GARD | 0023916 |
| Anatomy (UBERON) | UBERON:0036263 |
| Is cancer (heuristic) | yes |
Also known as: epidermoid carcinoma of supraglottis · epidermoid carcinoma of the supraglottis · squamous cell carcinoma of supraglottis · squamous cell carcinoma of the supraglottis · supraglottic epidermoid carcinoma · supraglottic part of larynx squamous cell carcinoma · supraglottic squamous cell carcinoma · supraglottis epidermoid carcinoma · supraglottis squamous cell carcinoma
Disease family
This is a subtype of carcinoma of supraglottis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › cancer › respiratory system cancer › larynx cancer › supraglottis cancer › carcinoma of supraglottis › supraglottis squamous cell carcinoma
Related subtypes (1): epiglottis cancer
Subtypes (1): supraglottis verrucous carcinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 4.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 4 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT02984410 | Not specified | ACTIVE_NOT_RECRUITING | Study Assessing The Best of Radiotherapy vs the Best of Surgery in Patients With Oropharyngeal Carcinoma |
| NCT05611515 | Not specified | RECRUITING | Treatment of Early Supraglottic Squamous Cell Carcinoma With Advance Technologies |
| NCT01819480 | Not specified | UNKNOWN | Efficacy and Safety of TORS for SCCA |
| NCT03357107 | Not specified | COMPLETED | Local Control After Robot-assisted Supraglottic Laryngectomy |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.